Latest Breaking News On - Head of the centre for psychedelic research - Page 1 : comparemela.com

Psychedelics clinical trial start-up Clerkenwell Health to sponsor PSYCH Symposium London 2023

Clerkenwell Health, a specialist clinical research organisation (CRO) focused on supporting clients with the design and delivery of psychedelic-assisted therapy trials, is pleased to announce its sponsorship of the upcoming PSYCH Symposium 2023 on Thursday 6 July in London. PSYCH Symposium 2023, hosted by PSYCH .

City ofUnited kingdomGeorge mcbrideCharlotte nicholsChristian angermayerCelia morganClare knightDavid erritzoeTadeusz hawrotSamir inamdarRobin carhart harrisTranspharmation ltdApeiron investment groupEuropean parliamentCybin incImperial college london

Tryp Therapeutics Reports on Key Milestones for 2021

Tryp Therapeutics Reports on Key Milestones for 2021
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesSan diegoCity ofUnited kingdomWilliam schmidtRobin carhart harrisJennifer millerGreg mckeeMarc lustigJoel castellanosUniversity of floridaHead of the centre for psychedelic researchTryp therapeutics incAlbany molecular research incCalifornia newsfile corpUc san diego medical center

Tryp Therapeutics Inc : Tryp Therapeutics Reports on Key Milestones for 2021

Tryp Therapeutics Inc : Tryp Therapeutics Reports on Key Milestones for 2021
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Mydecine Innovations Group Partners with Microdose Psychedelic Insights to Present a Free, Live Webinar Series on The Renaissance of Psychedelics

Mydecine Innovations Group Partners with Microdose Psychedelic Insights to Present a Free, Live Webinar Series on The Renaissance of Psychedelics Mydecine Innovations Group an emerging biopharma and life sciences company committed to the research, development, and acceptance of alternative nature-sourced therapeutic medicine for mainstream use, announced today that the Company has partnered with Microdose Psychedelic Insights a leader in B2B psychedelic intelligence, to present a free, three-part live video discussion series titled “Mydecine Speaker … The first Mydecine Carhart Roscow Yeji Lee, Business Insider reporter, the panelists will discuss the impact of cutting edge research in mainstream medical interest about unlocking the potential of psychedelic therapies

United statesCity ofUnited kingdomRakesh jetlyRuth laniusRobin carhartRobin carhart harrisJoshua bartchCharles leeHyeji leeAnne donohoe nick opichCorp communicationMydecine innovations group media contactsMydecine innovations groupHead of the centre for psychedelic researchImperial college london